GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ildong Pharmaceutical Co Ltd (XKRX:249420) » Definitions » Debt-to-Asset

Ildong Pharmaceutical Co (XKRX:249420) Debt-to-Asset : 0.33 (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Ildong Pharmaceutical Co Debt-to-Asset?

Ildong Pharmaceutical Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₩119,676 Mil. Ildong Pharmaceutical Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₩75,209 Mil. Ildong Pharmaceutical Co's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was ₩590,461 Mil. Ildong Pharmaceutical Co's debt to asset for the quarter that ended in Sep. 2024 was 0.33.


Ildong Pharmaceutical Co Debt-to-Asset Historical Data

The historical data trend for Ildong Pharmaceutical Co's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ildong Pharmaceutical Co Debt-to-Asset Chart

Ildong Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial 0.27 0.28 0.32 0.32 0.35

Ildong Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.35 0.36 0.36 0.33

Competitive Comparison of Ildong Pharmaceutical Co's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Ildong Pharmaceutical Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ildong Pharmaceutical Co's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ildong Pharmaceutical Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Ildong Pharmaceutical Co's Debt-to-Asset falls into.



Ildong Pharmaceutical Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Ildong Pharmaceutical Co's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(181246.518 + 31479.481) / 611260.857
=0.35

Ildong Pharmaceutical Co's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(119675.812 + 75209.411) / 590460.96
=0.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ildong Pharmaceutical Co  (XKRX:249420) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Ildong Pharmaceutical Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Ildong Pharmaceutical Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Ildong Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
2 Baumoe-ro 27-gil, Seocho-gu, Seoul, KOR, 137-733
Ildong Pharmaceutical Co Ltd is a Korean company which is engaged in manufacturing pharmaceutical products. Its product portfolio includes generic drugs and specialty drugs, such as vitamin supplements, digestive medications, vascular medications, probiotics, topical applications, antihistamines, antipyretics, analgesics, respiratory medications, endocrine medications, psycho-neurological medications, dermatological medications, urologic medications, antibiotics and others. The company also provides raw materials such as synthesizes, probiotics and others.

Ildong Pharmaceutical Co Headlines

No Headlines